|
SQLE expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.00761629542967E-12 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.20157225783169E-13 |
| Normal-vs-Stage2 |
1.808210E-02 |
| Normal-vs-Stage3 |
2.5930000369101E-09 |
| Normal-vs-Stage4 |
1.94932958663685E-12 |
| Stage1-vs-Stage2 |
7.788300E-02 |
| Stage1-vs-Stage3 |
7.052000E-01 |
| Stage1-vs-Stage4 |
1.917610E-01 |
| Stage2-vs-Stage3 |
1.464800E-01 |
| Stage2-vs-Stage4 |
2.198300E-02 |
| Stage3-vs-Stage4 |
1.863210E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.91433543964104E-13 |
| Normal-vs-AfricanAmerican |
9.39790000265006E-08 |
| Normal-vs-Asian |
2.3239965507571E-11 |
| Caucasian-vs-AfricanAmerican |
6.147400E-01 |
| Caucasian-vs-Asian |
2.337800E-01 |
| AfricanAmerican-vs-Asian |
8.066200E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.92560001277542E-09 |
| Normal-vs-Female |
2.55462317966249E-13 |
| Male-vs-Female |
4.847000E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.65356617287671E-12 |
| Normal-vs-Age(41-60Yrs) |
2.06168415672892E-13 |
| Normal-vs-Age(61-80Yrs) |
7.758100E-03 |
| Normal-vs-Age(81-100Yrs) |
8.836600E-04 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
8.727800E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.060770E-03 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
6.678600E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.236110E-03 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
6.972800E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
1.728830E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
4.794400E-01 |
| Classical-VS-Follicular |
2.771700E-04 |
| Classical-VS-Other |
1.047630E-01 |
| Classical-VS-Normal |
1.63324909152607E-12 |
| Tall-VS-Follicular |
6.751400E-04 |
| Tall-VS-Other |
4.617800E-01 |
| Tall-VS-Normal |
3.97319954714703E-10 |
| Follicular-VS-Other |
1.972220E-04 |
| Follicular-VS-Normal |
1.691930E-02 |
| Other-VS-Normal |
3.20860000002643E-06 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.06400008195828E-10 |
| Normal-vs-N1 |
<1E-12 |
| N0-vs-N1 |
9.74330000014234E-07 |
|
|
